Companies: 10,795·Total market cap: $144.5T
Atlantic International Corp.

Atlantic International Corp.

ATLNNASDAQHealthcare● Active
$0.84
+$0.07(+8.51%)
Market Cap$66494294
P/E Ratio
52W High$5.25
52W Low$0.65

Atlantic International Corp. (ATLN) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

atln · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Atlantic International Corp. (ATLN) measures how much investors pay for each dollar of the company's trailing earnings. ATLN's current PE ratio of N/A is calculated by dividing its stock price of $0.84 by its TTM earnings per share of -$1.08.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2026 est. EPS $-0.61
Based on 1 analyst
EPS (TTM)
-$1.08
TTM · diluted EPS
PEG Ratio
-0.01
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Atlantic International Corp. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2016 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Diagnostics & Research · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Atlantic International Corp.
Atlantic International Corp.You
ATLN
$66MN/A-$1.08
Anteris Technologies Global Corp.
Anteris Technologies Global Corp.
AVR
$344MN/A-$3.99
Cybin Inc.
Cybin Inc.
CYBN
$413MN/A-$0.61
Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc.
IMDX
$161MN/A-$1.65
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc.
MIST
$106MN/A-$0.75
Nkarta, Inc.
Nkarta, Inc.
NKTX
$176MN/A-$1.41
PepGen Inc.
PepGen Inc.
PEPG
$93MN/A-$2.12

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 10 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-1.08
2024-12-31
FY2024
$-3.68
2023-12-31
FY2023
$-0.60
2022-12-31
FY2022
$-0.15
2021-12-31
FY2021
$-1.88
2020-12-31
FY2020
$-0.05
2019-12-31
FY2019
$-0.12
2018-12-31
FY2018
$-0.14
2017-12-31
FY2017
$-0.11
2016-12-31
FY2016
$-0.09

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Atlantic International Corp. (ATLN) measures how much investors pay for each dollar of the company's trailing earnings. ATLN's current PE ratio of N/A is calculated by dividing its stock price of $0.84 by its TTM earnings per share of -$1.08.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.84 ÷ -$1.08 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

ATLN pe ratio · 6 questions

ATLN's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.84 and TTM EPS of -$1.08. Data sourced from Financial Modeling Prep via ATLN's SEC 10-K and 10-Q filings.

ATLN PE ratioWhat is ATLN PE ratioCurrent PE ratio of ATLNATLN PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Atlantic International Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09